SEC
SlamSEC
Search
Browse
Earnings
bioAffinity Technologies, Inc. — SlamSEC
bioAffinity Technologies, Inc.
Nasdaq:
BIAF
Nasdaq:
BIAFW
Services-Commercial Physical & Biological Research
·
SAN ANTONIO, TX
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
CEO
Zannes Maria
CFO
Edwards James Michael
Revenue
$2.5M
+52627.4% YoY
FY 2024
Adj. EBITDA
-$7.7M
-305.0% margin
FY 2024
Net Income
-$7.9M
-313.4% margin
FY 2024
EPS (Diluted)
-$0.91
FY 2024
Stock Price
$1.13
-5.0%
2026-03-11
52W Range
$0.69 – $46.53
P/E Ratio
-1.2x
Market Cap
$5.1M
Cash
$2.8M
FY 2024
Total Debt
$191,849
FY 2024
Net Cash
$2.6M
FY 2024
Enterprise Value
$2.5M
Debt / EBITDA
0.3x
FY 2024
EV / EBITDA
-0.3x
Employees
—